Status:
COMPLETED
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
Lead Sponsor:
Novan, Inc.
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-40 years
Phase:
PHASE1
Brief Summary
In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.
Detailed Description
This study is to evaluate local cutaneous effects, including intensity and duration of erythema and changes in pH following 5 applications (twice daily for two days and once daily on the third day) of...
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- Women who are pregnant or nursing
- Subject with known sensitivity to a component of the test materials
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT02250430
Start Date
September 1 2014
End Date
September 1 2014
Last Update
November 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KGL
Broomall, Pennsylvania, United States, 19008